A comprehensive, MENA-focused approach integrating polygenic risk scores (PRS), monogenic variant testing, clinical factors, and lifestyle to deliver individualized prostate cancer prevention strategies.
Learn more
A comprehensive, MENA-focused approach integrating polygenic risk scores (PRS), monogenic variant testing, clinical factors, and lifestyle to deliver individualized breast cancer prevention strategies.
Learn more
This NEJM 2026 review supports DNA-based population screening with PRS as a key tool for
risk-stratified prevention allowing targeted, earlier interventions.
Learn more
This NEJM 2026 review shows that CAD polygenic risk scores (PRS) identify a high-risk group, often missed by traditional calculators and meaningfully improve risk prediction and provide absolute benefit is greatest in high-PRS individuals.
Learn more
This landmark JAMA 2025 trial showed that PRS-powered risk-based breast cancer screening was non-inferior to annual screening and was associated with an approximately one-third lower rate of advanced cancer.
This landmark JAMA 2025 WISDOM trial showed that PRS-powered risk-based breast cancer screening was non-inferior to annual screening and was associated with an approximately one-third lower rate of advanced (stage ≥IIB) cancers (30.0 vs 48.0 per 100,000 person-years), with nearly doubled uptake of preventive therapy among the highest-risk women, establishing PRS-guided screening as a scalable and clinically sound strategy.
Learn more
This landmark NEJM 2025 study showed that PRS-guided screening of men in the top genetic risk decile substantially improves detection of clinically significant prostate cancer, uncovering many high-risk cancers missed by standard PSA pathways, and establishes PRS-based risk stratification as a scalable, clinically impactful screening strategy.
Learn more
Download this cardiometabolic genomics/PRS presentation to understand how genetic risk insights can help guide prevention, lifestyle planning, and personalized long-term health management.
Learn more
Explore this presentation on coronary artery disease genomics/PRS to discover how genomic risk evaluation supports early identification, prevention planning, and smarter cardiovascular care.
Learn more
Access this educational presentation on breast cancer genomics/PRS to learn how advanced genetic risk assessment can inform early detection strategies and enable more personalized preventive care.
Learn more
Download this educational presentation on prostate cancer genomics/polygenic risk scoring (PRS) to learn how advanced genetic insights help assess individual risk, support earlier detection, and guide personalized, proactive care decisions.
Learn more
